BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest. 1995;95:2581-2586. [PMID: 7769100 DOI: 10.1172/jci117959] [Cited by in Crossref: 145] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Newton J, Francis R, Prince M, James O, Bassendine M, Rawlings D, Jones D. Osteoporosis in primary biliary cirrhosis revisited. Gut. 2001;49:282-287. [PMID: 11454807 DOI: 10.1136/gut.49.2.282] [Cited by in Crossref: 80] [Cited by in F6Publishing: 60] [Article Influence: 4.0] [Reference Citation Analysis]
2 Mounach A, Ouzzif Z, Wariaghli G, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A, El Maghraoui A. Primary biliary cirrhosis and osteoporosis: a case-control study. J Bone Miner Metab. 2008;26:379-384. [PMID: 18600405 DOI: 10.1007/s00774-007-0833-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
3 Patel N, Muñoz SJ. Bone disease in cirrhosis. Clin Liver Dis (Hoboken) 2015;6:96-9. [PMID: 31040999 DOI: 10.1002/cld.498] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
4 Moon SS, Lee YS, Kim SW. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine. 2012;42:423-429. [PMID: 22407492 DOI: 10.1007/s12020-012-9639-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
5 Pusl T, Beuers U. Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy. Clin Rev Allergy Immunol. 2005;28:147-157. [PMID: 15879620 DOI: 10.1385/criai:28:2:147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 Fan J, Wang Q, Sun L. Association between primary biliary cholangitis and osteoporosis: meta-analysis. Clin Rheumatol 2017;36:2565-71. [PMID: 28948408 DOI: 10.1007/s10067-017-3844-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ferencz V, Horváth C, Kári B, Gaál J, Mészáros S, Wolf Z, Hegedus D, Horváth A, Folhoffer A, Szalay F. Bone disorders in experimentally induced liver disease in growing rats. World J Gastroenterol 2005;11:7169-73. [PMID: 16437666 DOI: 10.3748/wjg.v11.i45.7169] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
8 Boone RH, Cheung AM, Girlan LM, Heathcote EJ. Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin. Dig Dis Sci. 2006;51:1103-1112. [PMID: 16865577 DOI: 10.1007/s10620-006-8015-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
9 Levy C, Lindor KD. Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Curr Treat Options Gastroenterol. 2003;6:93-103. [PMID: 12628068 DOI: 10.1007/s11938-003-0010-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
10 Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Phatharacharukul P, Ungprasert P. Hepatitis C virus infection and risk of osteoporosis: A meta-analysis. Saudi J Gastroenterol 2017;23:216-21. [PMID: 28721974 DOI: 10.4103/sjg.SJG_452_16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Nakchbandi IA, van der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol. 2009;6:660-670. [PMID: 19881518 DOI: 10.1038/nrgastro.2009.166] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
12 Malik A, Kardashian AA, Zakharia K, Bowlus CL, Tabibian JH. Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist. Liver Res 2019;3:118-27. [PMID: 32042471 DOI: 10.1016/j.livres.2019.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, Cecchetti L, Minguzzi L, Gasbarrini G, Bernardi M. Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci. 2000;45:1392-1399. [PMID: 10961720 DOI: 10.1023/a:1005568406664] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
14 Nakchbandi IA. Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications. World J Gastroenterol. 2014;20:9427-9438. [PMID: 25071337 DOI: 10.3748/wjg.v20.i28.9427] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
15 Ehnert S, Aspera-Werz RH, Ruoß M, Dooley S, Hengstler JG, Nadalin S, Relja B, Badke A, Nussler AK. Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development. Int J Mol Sci 2019;20:E2555. [PMID: 31137669 DOI: 10.3390/ijms20102555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Luxon BA. Bone disorders in chronic liver diseases. Curr Gastroenterol Rep 2011;13:40-8. [PMID: 21104208 DOI: 10.1007/s11894-010-0166-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
17 Danford CJ, Trivedi HD, Papamichael K, Tapper EB, Bonder A. Osteoporosis in primary biliary cholangitis. World J Gastroenterol 2018;24:3513-20. [PMID: 30131657 DOI: 10.3748/wjg.v24.i31.3513] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
18 Bredella MA, Gill CM, Gerweck AV, Landa MG, Kumar V, Daley SM, Torriani M, Miller KK. Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology 2013;269:534-41. [PMID: 23861502 DOI: 10.1148/radiology.13130375] [Cited by in F6Publishing: 50] [Reference Citation Analysis]
19 Maalouf NM, Sakhaee K. Treatment of osteoporosis in patients with chronic liver disease and in liver transplant recipients. Curr Treat Options Gastroenterol 2006;9:456-63. [PMID: 17081479 DOI: 10.1007/s11938-006-0002-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
20 Huang Z, Wei H, Cheng C, Yang S, Wang J, Liu X. Low bone mineral density in chronic hepatitis B virus infection: A case-control study. Pak J Med Sci 2017;33:457-61. [PMID: 28523056 DOI: 10.12669/pjms.332.12099] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
21 Minuk GY, Greenberg R, Uhanova J, Hawkins K, Leslie WD. Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study. Can J Gastroenterol 2009;23:431-6. [PMID: 19543574 DOI: 10.1155/2009/635126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
22 Iruzubieta P, Teran A, Crespo J, Fabrega E. Vitamin D deficiency in chronic liver disease. World J Hepatol. 2014;6:901-915. [PMID: 25544877 DOI: 10.4254/wjh.v6.i12.901] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
23 Portincasa P, Vacca M, Moschetta A, Petruzzelli M, Palasciano G, van Erpecum KJ, van Berge-Henegouwen GP. Primary sclerosing cholangitis: updates in diagnosis and therapy. World J Gastroenterol 2005;11:7-16. [PMID: 15609388 DOI: 10.3748/wjg.v11.i1.7] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
24 Lindor KD, Kowdley KV, Harrison ME; American College of Gastroenterology. ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol. 2015;110:646-59; quiz 660. [PMID: 25869391 DOI: 10.1038/ajg.2015.112] [Cited by in Crossref: 254] [Cited by in F6Publishing: 147] [Article Influence: 42.3] [Reference Citation Analysis]
25 Chen TL, Lin CS, Shih CC, Huang YF, Yeh CC, Wu CH, Cherng YG, Liao CC. Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies. BMJ Open 2017;7:e017342. [PMID: 28993387 DOI: 10.1136/bmjopen-2017-017342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
26 Bredella MA, Gill CM, Gerweck AV, Landa MG, Kumar V, Daley SM, Torriani M, Miller KK. Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology 2013;269:534-41. [PMID: 23861502 DOI: 10.1148/radiology.13130375] [Cited by in Crossref: 80] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
27 Santos LA, Romeiro FG. Diagnosis and Management of Cirrhosis-Related Osteoporosis. Biomed Res Int. 2016;2016:1423462. [PMID: 27840821 DOI: 10.1155/2016/1423462] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
28 Bishi DK, Mathapati S, Cherian KM, Guhathakurta S, Verma RS. In vitro hepatic trans-differentiation of human mesenchymal stem cells using sera from congestive/ischemic liver during cardiac failure. PLoS One 2014;9:e92397. [PMID: 24642599 DOI: 10.1371/journal.pone.0092397] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
29 Gasser RW. Cholestasis and metabolic bone disease - a clinical review. Wien Med Wochenschr. 2008;158:553-557. [PMID: 18998071 DOI: 10.1007/s10354-008-0594-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
30 Guerra-Menéndez L, Sádaba MC, Puche JE, Lavandera JL, de Castro LF, de Gortázar AR, Castilla-Cortázar I. IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. J Transl Med 2013;11:271. [PMID: 24161214 DOI: 10.1186/1479-5876-11-271] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
31 Floreani A, Mega A, Camozzi V, Baldo V, Plebani M, Burra P, Luisetto G. Is osteoporosis a peculiar association with primary biliary cirrhosis? World J Gastroenterol 2005;11:5347-50. [PMID: 16149144 DOI: 10.3748/wjg.v11.i34.5347] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
32 Heathcote J. Osteoporosis in chronic liver disease. Curr Gastroenterol Rep. 1999;1:455-458. [PMID: 10980986 DOI: 10.1007/s11894-999-0001-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
33 Homchan K, Chaiwatanarat T, Udomsinprasert W, Chongsrisawat V, Poovorawan Y, Honsawek S. Low bone mineral density and the severity of cholestasis in biliary atresia. World J Hepatol 2017;9:746-51. [PMID: 28652893 DOI: 10.4254/wjh.v9.i16.746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
34 McPhee F, Caldera PS, Bemis GW, McDonagh AF, Kuntz ID, Craik CS. Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J 1996;320 ( Pt 2):681-6. [PMID: 8973584 DOI: 10.1042/bj3200681] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
35 López-Larramona G, Lucendo AJ, González-Castillo S, Tenias JM. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World J Hepatol. 2011;3:300-307. [PMID: 22216370 DOI: 10.4254/wjh.v3.i12.300] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
36 Kawazoe Y, Miyauchi M, Nagasaki A, Furusho H, Yanagisawa S, Chanbora C, Inubushi T, Hyogo H, Nakamoto T, Suzuki K, Moriwaki S, Tazuma S, Niida S, Takata T. Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-γ-Glutamyl Transpeptidase Antibody. PLoS One 2015;10:e0139620. [PMID: 26418133 DOI: 10.1371/journal.pone.0139620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
37 Angulo P, Grandison GA, Fong DG, Keach JC, Lindor KD, Bjornsson E, Koch A. Bone disease in patients with primary sclerosing cholangitis. Gastroenterology 2011;140:180-8. [PMID: 20955707 DOI: 10.1053/j.gastro.2010.10.014] [Cited by in Crossref: 75] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
38 Pusl T, Beuers U. Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy. Clin Rev Allergy Immunol. 2005;28:147-157. [PMID: 15879620 DOI: 10.1385/criai:] [Reference Citation Analysis]
39 Hajiabbasi A, Shafaghi A, Fayazi HS, Shenavar Masooleh I, Hedayati Emami MH, Ghavidel Parsa P, Amir Maafi A. The factors affecting bone density in cirrhosis. Hepat Mon 2015;15:e26871. [PMID: 25977695 DOI: 10.5812/hepatmon.15(4)2015.26871] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]